http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150015671-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2013-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150015671-A |
| titleOfInvention | Pharmaceutical Composition for Treatment and Prevention of Brain Disease |
| abstract | The present invention relates to a pharmaceutical composition for the treatment and prevention of brain diseases caused by glutamate mediated neurotoxicity, a health functional food for lowering cognitive function and improving damage, and more particularly, HT) as an active ingredient for the treatment and prevention of brain diseases. At this time, the acyl group represents an acyl group derived from C16-C22 saturated or unsaturated fatty acid. |
| priorityDate | 2013-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.